Mark For: THIOMAB® trademark registration is intended to cover the category of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88606375 |
Registration Number | 6151018 |
Mark Literal Elements | THIOMAB |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | TMO LAW OFFICE 119 - EXAMINING ATTORNEY ASSIGNED 2019-11-21 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Shameek Ghose |
Attorney Docket Number | TM-40404-US |
Law Office Assigned | N10 |
Employee Name | RITTNER, HANNO I |
2019-08-26 | Date of First Use |
2019-08-26 | Date of Use In Commerce |
2019-09-05 | Application Filed |
2019-11-21 | Location: TMO LAW OFFICE 119 - EXAMINING ATTORNEY ASSIGNED |
2019-11-21 | Status: A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additi |
2019-11-21 | Status: Live/Pending |
2019-11-21 | Transaction Date |
2020-09-15 | Trademark Registered |
Party: | ![]() |
Address | 1 DNA WAY SOUTH SAN FRANCISCO, CALIFORNIA UNITED STATES 940804990 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
![]() | 2019-09-05 | |
![]() | 2019-09-05 | |
![]() | 2019-09-05 | |
![]() | 2019-11-21 | |
![]() | APPLICATION/XML | 2019-11-21 |
![]() | 2020-05-20 | |
![]() | 2020-05-22 | |
![]() | 2020-05-23 | |
![]() | 2020-06-10 | |
![]() | 2020-06-10 | |
![]() | 2020-06-30 | |
![]() | 2020-09-15 | |
![]() | 2021-04-19 | |
![]() | 2021-08-11 |
IC 001. US 001 005 006 010 026 046. G & S: Antibody technology platform used to incorporate cysteines into an antibody, namely, protein arrays and nucleotide arrays for scientific and medical research. FIRST USE: 20190826. FIRST USE IN COMMERCE: 20190826
IC 005. US 006 018 044 046 051 052. G & S: Antibody technology platform used to incorporate cysteines into an antibody, namely, protein arrays for medical diagnosis purposes. FIRST USE: 20190826. FIRST USE IN COMMERCE: 20190826
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | antibody technology platform used to incorporate cysteines into an antibody |
GS0011 | Antibody technology platform used to incorporate cysteines into an antibody, namely, protein arrays and nucleotide arrays for scientific and medical research |
Description | Date | Proceeding Number |
---|---|---|
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2021-08-11 | |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-08-11 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-08-11 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-08-11 | |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-04-19 | |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-04-19 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-04-19 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-04-19 | |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-04-19 | 88888 |
REGISTERED-PRINCIPAL REGISTER | 2020-09-15 | |
PUBLISHED FOR OPPOSITION | 2020-06-30 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-06-30 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-06-10 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-05-22 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-05-21 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-05-20 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-05-20 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-11-21 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-11-21 | 76746 |
NON-FINAL ACTION E-MAILED | 2019-11-21 | 6325 |
ASSIGNED TO EXAMINER | 2019-11-21 | 76746 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-09-17 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2019-09-17 | |
NEW APPLICATION ENTERED IN TRAM | 2019-09-09 | |
NEW APPLICATION ENTERED | 2019-09-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.